Change to Board Committees

GlaxoSmithKline PLC
17 May 2004

Issued - Monday 17th May 2004, London - LSE Announcement



                              GlaxoSmithKline plc
                  Announces Changes to the Board's Committees



Board Committees

Remuneration Committee

The Board has appointed Sir Robert Wilson to succeed Mr McArthur as Chairman of
the Remuneration Committee with immediate effect. Mr McArthur is to retire from
the Board at the conclusion of today's Annual General Meeting.

Nominations Committee

The Board has appointed Dr Ronaldo Schmitz a member of the Nominations
Committee, with immediate effect.

Corporate Responsibility Committee

The Board has appointed Sir Christopher Hogg to Chair the Corporate
Responsibility Committee, on an interim basis, following the retirement of Mr
McHenry from the Board at the conclusion of the AGM. The Board has also
appointed Sir Ian Prosser a member of the Committee following Dr Barzach's
retirement from the conclusion of the AGM.

S M Bicknell

Company Secretary

17th May 2004



                            ________________________





                           Board Committee Membership

                        with effect from 17th May 2004.






 Board Committee          Committee Chairman        Members


Audit                     Dr Ronaldo Schmitz        Sir Peter Job

                                                    Sir Ian Prosser

                                                    Sir Robert Wilson

Remuneration               Sir Robert Wilson        Mr H Lawrence Culp Jnr.

                                                    Mr Crispin Davis

                                                    Sir Peter Job


Nominations               Sir Christopher Hogg      Sir Ian Prosser

                                                    Dr Ronaldo Schmitz

                                                    
Corporate Responsibility  Sir Christopher Hogg      Sir Ian Prosser

                          (Interim Chairman)        Dr Lucy Shapiro







GSK Enquiries:
UK Media enquiries:                                    Martin Sutton            [phone]
                                                       David Mawdsley           [phone]
                                                       Chris Hunter-Ward        [phone]

US Media enquiries:                                    Nancy Pekarek            [phone]
                                                       Mary Anne Rhyne          [phone]
                                                       Patricia Seif            [phone]

European Analyst/Investor enquiries:                   Duncan Learmouth         [phone]
                                                       Anita Kidgell            [phone]
                                                       Philip Thomson           [phone]

US Analyst/ Investor enquiries:                        Frank Murdolo            [phone]
                                                       Tom Curry                [phone]




                      This information is provided by RNS
            The company news service from the London Stock Exchange